CME Group and Morningstar Announce Exclusive Index Derivatives Licensing Agreement
Rhea-AI Summary
CME Group (NASDAQ:CME) and Morningstar entered a multi-year, exclusive licensing agreement for index derivatives. CME Group will launch derivatives based on key Morningstar US equity index benchmarks, including Total Market, Large Cap, Value, Growth, Mid Cap, and Small Cap Indexes.
The Morningstar Market Indexes, currently rebranding from CRSP, underpin over $3 trillion in linked assets. The partnership introduces derivatives on these benchmarks for the first time, aiming to expand risk management tools for global investors.
Positive
- Exclusive multi-year licensing agreement for Morningstar equity index derivatives
- New CME derivatives on indexes linked to over $3 trillion in assets
- Morningstar gains derivatives exposure via CME Group’s global marketplace
- CME expands equity index benchmark offering across US market size segments
Negative
- None.
News Market Reaction – MORN
On the day this news was published, MORN declined 4.79%, reflecting a moderate negative market reaction. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $339M from the company's valuation, bringing the market cap to $6.75B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 04 | AI integration launch | Positive | +1.8% | PitchBook integration with Harvey for AI-driven private markets workflows. |
| Jun 04 | AI analytics launch | Positive | +1.8% | AI access to CRE surveillance and CMBS analytics via Anthropic’s Claude. |
| May 27 | Survey insights | Neutral | -0.6% | Asset owner perspectives on markets, AI, and sustainability themes. |
| May 20 | Product launch | Positive | -0.9% | Corporate Credit Analytics platform for standardized private credit analysis. |
| May 08 | Platform integration | Positive | -0.7% | Morningstar and PitchBook research integration into Perplexity via MCP. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent product and AI-integration announcements often coincided with modest positive price reactions, while some broader strategic or survey updates saw mild weakness.
Over the past month, Morningstar issued several product and AI-integration updates, including PitchBook’s Harvey connector and Morningstar Credit Analytics’ AI access, both followed by +1.76% moves. Other news, such as survey insights and platform launches in private credit, saw small declines between -0.60% and -0.95%. The new CME Group licensing agreement continues a pattern of partnerships that expand data and index usage, aligning with earlier strategic integrations.
Key Terms
derivatives financial
equity index benchmarks financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Through this exclusive agreement, CME Group will offer derivatives on the Morningstar Market Indexes, currently rebranding from CRSP, for the first time, enabling clients to utilize derivatives based on the indexes which underpin over
"We are pleased to partner with Morningstar to help unlock more precise, next-generation risk management tools for the global investment community," said Tim McCourt, CME Group Senior Managing Director and Global Head of Equities, FX and Alternative Products. "Together, CME Group's deeply liquid equity derivatives marketplace paired with Morningstar's data-driven, benchmark ecosystem is expected to allow us to provide our global clients with an optimized framework to safely navigate market volatility and capture new opportunities."
"We're excited to collaborate with CME Group to offer derivative products for the first time on the Morningstar Market Indexes, the most definitive and comprehensive measures of the US equity market," added Morningstar Indexes President Amelia Furr. "With our acquisition of CRSP earlier this year, we have become a leading provider of
About CME Group
As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and
About Morningstar, Inc.
Morningstar, Inc. is a leading provider of independent investment insights in
Caution Concerning Forward-Looking Statements
This press release contains forward-looking statements as that term is used in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations about future events or future financial performance. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, and often contain words such as "aim," "committed," "consider," "estimate," "future," "goal," "is designed to," "maintain," "may," "might," "objective," "ongoing," "could," "expect," "intend," "plan," "possible," "potential," "seek," "anticipate," "believe," "predict," "prospects," "continue," "strategy," "strive," "will," "would," "determine," "evaluate," or the negative thereof, and similar expressions. These statements involve known and unknown risks and uncertainties that may cause the events we discuss not to occur or to differ significantly from what we expect. These risks and uncertainties include, among others, failing to achieve the anticipated benefits of the licensing agreement between CME Group and Morningstar. If any of these risks and uncertainties materialize, actual future results and other future events may vary significantly from what we expect. We do not undertake to update our forward-looking statements as a result of new information, future events or otherwise, except as may be required by law. You are, however, advised to review any further disclosures we make on related subjects, and about new or additional risks, uncertainties and assumptions in our future filings with the SEC on Forms 10-K, 10-Q, and 8-K. This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction.
About Morningstar Indexes
Morningstar Indexes was built to keep up with the evolving needs of investors—and to be a leading-edge advocate for them. Morningstar's rich heritage as a transparent, investor-focused leader in data and research uniquely equips Morningstar Indexes to support individuals, institutions, wealth managers and advisors in navigating investment opportunities across all major asset classes, styles, and strategies. In February 2026, the acquisition of CRSP brought the CRSP Market Indexes – benchmarks for over
CME-G
MORN-C
View original content:https://www.prnewswire.com/news-releases/cme-group-and-morningstar-announce-exclusive-index-derivatives-licensing-agreement-302797286.html
SOURCE CME Group; Morningstar, Inc.